ÂÜÀòÂÒÂ×

Rochelle Riley has been working in the field of bioanalytical sciences since 1998. Rochelle began their career as a Bioanalytical Scientist at KCAS Bioanalytical & Biomarker Services, before moving on to become a Scientist at Sekisui XenoTech, LLC in 2000. In 2005, they joined Monsanto as a Mass Spectrometry bioanalytical Scientist (Crop Analytics). Rochelle then moved to Pfizer in 2007, where they worked as an ADME Bioanalytical Scientist. In 2010, they were hired as a Bioanalytical Scientist at Seventh Wave Laboratories, and in 2011, they became an Analytical Scientist at Mallinckrodt Pharmaceuticals. Finally, in 2017, they were appointed as Principal Research Scientist at MediBeacon Inc.

Rochelle Riley attended Hutchinson Community College from 1993 to 1995, studying Pre-Pharmacy. Rochelle then attended New Mexico State University from 1995 to 1998, earning a BS in Microbiology. In addition, they have obtained a Design for Six Sigma Black Belt certification from Mallinckrodt Pharmaceuticals.